You and I were both mentioning that before on the boards. I expect it will cover several autoimmune... highly reasonable are rheumatoid arthritis, ankylosing spondylitis, sgorens (sp), psoriatic arthritis, crohns disease. I am not sure about lupus it might not be an indication.

I and I am sure you will look into it.

All I know for certain is that Prurisol is a blockbuster in its own right. Once we have positive data from the POC IMO we are going up against methotrexate in phase III.

Then we are in competition with the biologics which are second line often added after methotrexate fails or in conjunction with methotrexate.